Advertisement

Topics

GSK and Immunocore Extend Targeted Cancer Collaboration

10:34 EDT 3 Jul 2017 | PharmPro

Immunocore announces third oncology target selected in discovery collaboration with GlaxoSmithKline. The program is part of an ongoing oncology discovery collaboration for multiple novel targets not addressable with antibody-based technologies.
Contributed Author: 
Immunocore Limited

Original Article: GSK and Immunocore Extend Targeted Cancer Collaboration

NEXT ARTICLE

More From BioPortfolio on "GSK and Immunocore Extend Targeted Cancer Collaboration"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...